Data gathered: September 7
Alternative Data for Ardelyx
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 27 | Sign up | Sign up | Sign up |
| Sentiment | 95 | Sign up | Sign up | Sign up |
| Webpage traffic | 21,000 | Sign up | Sign up | Sign up |
| Employee Rating | 80 | Sign up | Sign up | Sign up |
| Google Trends | 18 | Sign up | Sign up | Sign up |
| Patents | 33 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 13 | Sign up | Sign up | Sign up |
| Facebook Followers | 220 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 58 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 17,899 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,729 | Sign up | Sign up | Sign up |
| Twitter Mentions | 237 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 53 | Sign up | Sign up | Sign up |
| Linkedin Employees | 357 | Sign up | Sign up | Sign up |
About Ardelyx
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally.
| Price | $5.60 |
| Target Price | Sign up |
| Volume | 2,100,000 |
| Market Cap | $1.36B |
| Year Range | $5.28 - $9.74 |
| Dividend Yield | 0% |
| Industry | Biotechnology |
In the news
 |
Zurcher Kantonalbank Zurich Cantonalbank Increases Position in Ardelyx, Inc. (NASDAQ:ARDX)September 7 - ETF Daily News |
|
Allspring Global Investments Holdings LLC Cuts Holdings in Ardelyx, Inc. (NASDAQ:ARDX)September 7 - ETF Daily News |
ARDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ardelyx, Inc. Investors Can Join the Class Action Lawsuit!September 6 - GlobeNewswire |
|
Ardelyx, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your Rights - ARDXSeptember 5 - Finnhub |
|
ARDX Lawsuit Reminder - Robbins LLP Encourages Ardelyx, Inc. Stockholders to Seek Counsel for Class Action LawsuitSeptember 5 - GlobeNewswire |
|
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARDXSeptember 5 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 73M | 74M | -870,000 | -16M | -13M | -0.070 |
| Q1 '24 | 44M | 60M | -16M | -27M | -24M | -0.110 |
| Q4 '23 | 33M | 54M | -20M | -29M | -26M | -0.120 |
| Q3 '23 | 55M | 41M | 14M | 6.6M | 8.9M | 0.030 |
| Q2 '23 | 21M | 32M | -10M | -17M | -15M | -0.080 |
Insider Transactions View All
| RAAB MICHAEL filed to sell 1,219,509 shares at $6.2. August 28 '24 |
| Blanks Robert filed to sell 319,362 shares at $5.9. August 22 '24 |
| Felsch Robert Ora filed to sell 91,560 shares at $5.9. August 22 '24 |
| GRAMMER ELIZABETH A filed to sell 192,380 shares at $5.9. August 22 '24 |
| Renz Justin A filed to sell 295,257 shares at $5.9. August 22 '24 |
Similar companies
Read more about Ardelyx (ARDX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Ardelyx?
The Market Cap of Ardelyx is $1.36B.
What is the current stock price of Ardelyx?
Currently, the price of one share of Ardelyx stock is $5.60.
How can I analyze the ARDX stock price chart for investment decisions?
The ARDX stock price chart above provides a comprehensive visual representation of Ardelyx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ardelyx shares. Our platform offers an up-to-date ARDX stock price chart, along with technical data analysis and alternative data insights.
Does ARDX offer dividends to its shareholders?
As of our latest update, Ardelyx (ARDX) does not offer dividends to its shareholders. Investors interested in Ardelyx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Ardelyx?
Some of the similar stocks of Ardelyx are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.